Predicting and Reducing Future Health Disparities for U.S. Adults with Diabetes

预测和减少美国成人糖尿病患者未来的健康差异

基本信息

  • 批准号:
    9788527
  • 负责人:
  • 金额:
    $ 40.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-09-19 至 2022-04-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Disparities in diabetes and its complications have persisted, despite increased public health focus on reducing them. Compared to whites living with diabetes, blacks have a two-fold increased risk of stroke, amputation, and end-stage renal disease (ESRD); Hispanics and Asians have a 20 to 50% higher risk for eye problems, and at least an 80% higher risk of ESRD. Many interventions have been developed to reduce diabetes health disparities; however, despite accumulated evidence, adoption of interventions to eliminate disparities has been slow across healthcare organizations and payers. A critical barrier to developing and adopting policies to eliminate diabetes health disparities is the lack of long-term data on the economic and clinical impact of these interventions. Simulation models are mathematical representations of the complex relationships between predictors (e.g., hemoglobin A1c) and outcomes (e.g., ESRD) among specific populations. Diabetes simulation models have been used for over a decade to describe the cost-effectiveness of clinical guidelines, clinical interventions, and new drugs and devices. However, they have been rarely used to study the disparate impact between populations, i.e. health disparities. Without such a model, it is difficult to compare the relative value of different clinical and public health interventions to reduce health disparities and difficult for policymakers to decide where to allocate resources. The reason that such a model does not exist is that the majority of current diabetes simulation models rely on data from the UKPDS and other sources, which did not have large populations of Hispanic and/or Asian patients. The major challenge to developing a more useful multi-ethnic diabetes simulation model is the need to have comprehensive data across all domains of healthcare utilization, including clinically-measured risk factors (e.g., blood pressure and laboratory results) and race/ethnicity data. We will use data from Kaiser Permanente Northern California, a multi-ethnic, socioeconomically diverse population with diabetes (n~192,000) (16% Latino, 11% African American, 7% South Asian, 4% Chinese; 13% difficulty with English) to develop a mathematical model of the relationships between patient risk factors and outcomes using Kaiser data, and then to input national data and published data into the model in order to forecast the long-term implications of efforts to reduce diabetes health disparities. Our specific aims are to 1) develop a simulation model of diabetes outcomes for white, African American, Latino, South Asian, and Chinese populations; 2) forecast the impact of past changes in risk factor control on future diabetes health disparities; and 3) determine the cost-effectiveness of diabetes health disparities interventions.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Neda Laiteerapong其他文献

Neda Laiteerapong的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Neda Laiteerapong', 18)}}的其他基金

Achieving Equity in Patient Outcome Reporting for Timely Assessments of Life with HIV and Substance Use (ePORTAL HIV-S)
实现患者结果报告的公平性,以便及时评估艾滋病毒感染者和药物使用的生活(ePORTAL HIV-S)
  • 批准号:
    10740440
  • 财政年份:
    2023
  • 资助金额:
    $ 40.18万
  • 项目类别:
Predicting and Reducing Future Health Disparities for U.S. Adults with Diabetes
预测和减少美国成人糖尿病患者未来的健康差异
  • 批准号:
    9912648
  • 财政年份:
    2018
  • 资助金额:
    $ 40.18万
  • 项目类别:
Patient Outcomes Reporting for Timely Assessments of Life with Depression: PORTAL-Depression
及时评估抑郁症生活的患者结果报告:门户抑郁症
  • 批准号:
    9753157
  • 财政年份:
    2018
  • 资助金额:
    $ 40.18万
  • 项目类别:
Linking the Legacy Effect in Type 2 Diabetes to Clinical Decision Making
将 2 型糖尿病的遗留影响与临床决策联系起来
  • 批准号:
    8538972
  • 财政年份:
    2012
  • 资助金额:
    $ 40.18万
  • 项目类别:
Linking the Legacy Effect in Type 2 Diabetes to Clinical Decision Making
将 2 型糖尿病的遗留影响与临床决策联系起来
  • 批准号:
    8878245
  • 财政年份:
    2012
  • 资助金额:
    $ 40.18万
  • 项目类别:
Linking the Legacy Effect in Type 2 Diabetes to Clinical Decision Making
将 2 型糖尿病的遗留影响与临床决策联系起来
  • 批准号:
    8425302
  • 财政年份:
    2012
  • 资助金额:
    $ 40.18万
  • 项目类别:
Linking the Legacy Effect in Type 2 Diabetes to Clinical Decision Making
将 2 型糖尿病的遗留影响与临床决策联系起来
  • 批准号:
    8704929
  • 财政年份:
    2012
  • 资助金额:
    $ 40.18万
  • 项目类别:
Enrichment Program
强化计划
  • 批准号:
    10476594
  • 财政年份:
    2011
  • 资助金额:
    $ 40.18万
  • 项目类别:
Enrichment Program
强化计划
  • 批准号:
    10290678
  • 财政年份:
    2011
  • 资助金额:
    $ 40.18万
  • 项目类别:
Enrichment Program
强化计划
  • 批准号:
    10683200
  • 财政年份:
    2011
  • 资助金额:
    $ 40.18万
  • 项目类别:

相似海外基金

Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 40.18万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 40.18万
  • 项目类别:
    Collaborative R&D
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 40.18万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 40.18万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 40.18万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 40.18万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 40.18万
  • 项目类别:
    Operating Grants
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 40.18万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 40.18万
  • 项目类别:
    EU-Funded
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 40.18万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了